Moreover, an obviously improvement in M1-related inflammation medicators (TNF-α, IL-6, NO and iNOs) and suppression in M2-related anti-inflammation cytokines (IL-10 and Arg-1) emerged in psoriasis lesions in the skins of IMQ-treated mouse, which was consistent with previous reports. This evidence concerns the gene IL6 and psoriasis.